Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
2021
|
| In: |
American journal of hematology
Year: 2021, Volume: 96, Issue: 7, Pages: E253-E257 |
| ISSN: | 1096-8652 |
| DOI: | 10.1002/ajh.26191 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ajh.26191 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.26191 |
| Author Notes: | Christoph R. Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O. Schönland, Ute Hegenbart |
| Item Description: | Gesehen am 21.08.2023 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1096-8652 |
| DOI: | 10.1002/ajh.26191 |